Revive Therapeutics Engages Novotech as Asia-Pacific CRO for Bucillamine in the Treatment of Infectious Diseases

NEXT STORY
Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus Antigens
PREV STORY
Former US Ambassador and Assistant Director-General of the World Health Organization on HIV/AIDS, Tuberculosis and Malaria Dr. Jack C. Chow Joins Draganfly Board of Advisors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Junshi Biosciences Announces Acceptance by NMPA of Supplemental New Drug Application for Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

author_avatar
NASDAQ Market News

Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19

author_avatar
NASDAQ Market News

Avadim Health Announces Over-the-Counter Launch of Theraworx® Protect U-Pak

author_avatar
NASDAQ Market News